The application of Gln-glutamine in patients after liver transplantation
Author:
Affiliation:

Clc Number:

R 617

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Abstract:Objective:To explore the effects of Gln-glutamine (Gln-) supplemented TPN and traditional TPN on immunofunction, incidence of both rate of acute rejection and infection, and protein synthesis function of transplantation liver.
    Methods :Fifty patients with liver transplantation were randomly divided into two groups: group TPN without Gln- and group TPN with Gln-. Patients received isocaloric [104.6 kJ /(kg·d)] and isonitrogenous [(0.16g/(kg·d)] TPN for seven days. IgG,IgA,IgM, CD3,CD4/CD8, prealbumin(PAB) were monitored on the second and the ninth day after transplantation.
    Results:IgG, IgA, CD3, CD4 /CD8,PA levels of the group TPN with Gln- had significant elevation on the ninth day as compared to those on the second day after operation. The incidence rate of infection of the group TPN with Gln- was significantly lower than the group TPN without Gln-, while the incidence rate of acute rejection had no significant difference between the two groups.
    Conclusions:Gln-glutamine supplemented TPN can enhance the immunofunction of patients after liver transplantation, stimulate protein synthesis function and lower the incidence rate of infection, and does not increase the incidence of acute rejection.

    Reference
    Related
    Cited by
Get Citation

WAN Qiquan, YANG Mingshi, XIAO Xuefei, YE Qifa, Ma Ying, YANG Bingchang.The application of Gln-glutamine in patients after liver transplantation[J]. Chin J Gen Surg,2008,17(7):3-640.
DOI:10.7659/j. issn.1005-6947.2008.07.003

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 01,1900
  • Revised:January 01,1900
  • Adopted:
  • Online: July 25,2008
  • Published: